INFLAZOME LIMITED

Organization

  • IE

Patents Grantslast 30 patents

Patents Applicationslast 30 patents

  • Information Patent Application

    Compounds

    • Publication number 20250019355
    • Publication date Jan 16, 2025
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    COMPOUNDS

    • Publication number 20230121952
    • Publication date Apr 20, 2023
    • Inflazome Limited
    • Matthew COOPER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20230037255
    • Publication date Feb 2, 2023
    • INFLAZOME LIMITED
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TREATMENT OF AUTOINFLAMMATORY DISORDERS

    • Publication number 20220409585
    • Publication date Dec 29, 2022
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    TREATMENT AND PREVENTION OF NEUROINFLAMMATION OR AN INFLAMMATORY BR...

    • Publication number 20220409586
    • Publication date Dec 29, 2022
    • Inflazome Limited
    • Matthew COOPER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TREATMENT AND PREVENTION OF A NEURODEGENERATIVE DISORDER

    • Publication number 20220401414
    • Publication date Dec 22, 2022
    • Inflazome Limited
    • Matthew COOPER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TREATMENT OF ARTHRITIS

    • Publication number 20220395490
    • Publication date Dec 15, 2022
    • Inflazome Limited
    • Matthew COOPER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS

    • Publication number 20220389031
    • Publication date Dec 8, 2022
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MACROCYCLIC SULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

    • Publication number 20220289766
    • Publication date Sep 15, 2022
    • INFLAZOME LIMITED
    • Matthew COOPER
    • G01 - MEASURING TESTING
  • Information Patent Application

    NLRP3 INHIBITORS

    • Publication number 20220289692
    • Publication date Sep 15, 2022
    • Inflazome Limited
    • David MILLER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONAMIDEUREA COMPOUNDS

    • Publication number 20220194923
    • Publication date Jun 23, 2022
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NLRP3 INFLAMMASOME INHIBITION

    • Publication number 20220163539
    • Publication date May 26, 2022
    • Inflazome Limited
    • Matthew COOPER
    • G01 - MEASURING TESTING
  • Information Patent Application

    NOVEL SULFONEUREA COMPOUNDS

    • Publication number 20220106288
    • Publication date Apr 7, 2022
    • Inflazome Limited
    • Angus MACLEOD
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NLRP3 INHIBITORS

    • Publication number 20220106289
    • Publication date Apr 7, 2022
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL PROCESSES

    • Publication number 20220064125
    • Publication date Mar 3, 2022
    • Inflazome Limited
    • Daniel SCHWIZER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS

    • Publication number 20210347737
    • Publication date Nov 11, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PHENYLSULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

    • Publication number 20210332020
    • Publication date Oct 28, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Sodium Salt Of N-((1,2,3,5,6,7-Hexahydro-S-Indacen-4-Yl) Carbamoyl)...

    • Publication number 20210315862
    • Publication date Oct 14, 2021
    • Inflazome Limited
    • David MILLER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL COMPOUNDS

    • Publication number 20210261512
    • Publication date Aug 26, 2021
    • Inflazome Limited
    • David MILLER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    NOVEL SULFONEUREA COMPOUNDS

    • Publication number 20210163412
    • Publication date Jun 3, 2021
    • Inflazome Limited
    • Jonathan SHANNON
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PHENYLSULFONYLUREA DERIVATIVES USEFUL AS NLRP3 INHIBITORS

    • Publication number 20210147349
    • Publication date May 20, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

    • Publication number 20210130359
    • Publication date May 6, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

    • Publication number 20210130329
    • Publication date May 6, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

    • Publication number 20210122739
    • Publication date Apr 29, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS

    • Publication number 20210122716
    • Publication date Apr 29, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS

    • Publication number 20210047302
    • Publication date Feb 18, 2021
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS

    • Publication number 20210040065
    • Publication date Feb 11, 2021
    • Inflazome Limited
    • David MILLER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS

    • Publication number 20210002274
    • Publication date Jan 7, 2021
    • Inflazome Limited
    • Matthew COOPER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    SULFONAMIDE DERIVATES AS NLRP3 INHIBITORS

    • Publication number 20200407340
    • Publication date Dec 31, 2020
    • Inflazome Limited
    • Matthew COOPER
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NOVEL COMPOUNDS

    • Publication number 20200399243
    • Publication date Dec 24, 2020
    • Inflazome Limited
    • David MILLER
    • C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

  • Information Trademark

    79208982 - INFLAZOME TARGETED THERAPIES FOR INFLAMMATORY DISEASES

    • Serial number 79208982
    • Registration number 5592355
    • Filing date Feb 3, 2017
    • INFLAZOME LIMITED
    • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • Information Trademark

    79207295 - INFLAZOME

    • Serial number 79207295
    • Registration number 5430479
    • Filing date Feb 3, 2017
    • INFLAZOME LIMITED
    • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry